This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund and Teva Pharmaceuticals, as well as tech company Amazon Web Services, is currently accepting new applicants for its new challenge.
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and lifescience manufacturers drive efficiencies and business value while improving patient outcomes.
Tallying up the years between her working in physician practice management and the pharmaceutical sector, as well as time spent in health advocacy, “I’ve been 25 years in health care,” Stacy calculated. Parexel is a Clinical Research Organization that crafts and conducts clinical trials on behalf of lifescience companies.
This capability is attracting pharmaceutical and lifescience companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
Basel, Switzerland 28, January 2025 Lyfegen , a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA , a leading provider of global commercial services to the lifesciences industry, to revolutionize drug pricing and access through artificial intelligence-driven insights.
The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and lifesciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data. .”
About EVERSANA EVERSANA is a leading independent provider of global services to the lifesciences industry. The companys integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
BOSTON–( BUSINESS WIRE )– Labviva , the AI-driven lifesciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures.
Our mission is to accelerate the commercialization of breakthrough innovations like the AUTAC platform for health impact, and we welcome Automera and ALSP to Singapore’s growing lifesciences translational community.” Together, we advance Singapore as a global lifesciences translational hub.
The company offers payers, providers, and pharmaceutical companies the ability to transform claims and EHR datasets into analytics-ready data tables via an open-source data model with built-in normalization, data quality testing, and enrichment.
Abbott, one of the first lifescience companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech. .”
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. Note that Cigna acquired Express Scripts, the pharmacy benefit management company, last year which was the health insurance company’s on-ramp to lifesciences.
“push”) model where HCPs can access all the support they need from lifescience, insurance and pharmacy companies industry-wide, on their terms, in one place. They consider prescribing support from pharmaceutical companies and other institutions, if delivered in the right way, as helpful as ever.
CitiusTech , a leader in healthcare technology and consulting services, today announced that it has acquired Wilco Source , one of the world’s leading providers of Salesforce consulting and implementation services for healthcare and lifesciences companies. patient and provider portals) (Salesforce Communities).
” For this report, PwC’s Health Research Institute surveyed 2,511 American consumers, 128 health plan executives, 153 healthcare provider organization executives, and 124 pharmaceutical and lifesciences executives in August and September 2020. ” the report read. “Quite a bit, it turns out.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. .
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.
Pharma and lifescience companies to deliver holistic solutions for consumers’ self-care with digital companion apps, nutrition and exercise guidance that can complement medicines and bolster the drug’s benefits. Fitness collaborations with YMCAs and connected gyms that can scale exercise to us in our hands and homes.
In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. The marriage of AI and pharmaceuticals holds immense promise, particularly in the realm of drug discovery.
Tom Lawry may be best-known as a leading voice on AI in health care; after all, hes written two very well-selling books on the topic, speaks all over the world on the subject, and in his most recent company-based gig helped lead Microsofts efforts in AI in health care and lifesciences.
He sees three major developments: healthcare will become a digital-first system; decentralization will become a major theme for health and lifesciences organizations; and video will be part of every healthcare experience. You predict that decentralization will become a major theme for health and lifescience organizations.
The transaction was led by EQT LifeSciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. As part of the transactions, Drew Burdon of EQT LifeSciences will join the Board of Directors. About EQT LifeSciences. About FundamentalVR. billion (USD 3.5
And note how Americans’ trust in hospitals — historically the top-trusted health care segment in the nation — eroded from 2018, tying with consumer health companies, and just north of biotech and lifescience organizations. Even trust with pharmaceutical companies increased that year.
Fujitsu, Toppan tie up for big data analysis Japanese companies Fujitsu and Toppan have entered into a business alliance to offer advanced big data analysis services for hospital organisations and pharmaceutical companies.
I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer , with implications and calls-to-action for pharma and lifescience companies. You can download the paper at this link. The post The Patient as Prescription Drug Payer – The GoodRx Playbook appeared first on HealthPopuli.com.
IT vendor Salesforce is rolling out new healthcare tools designed to help healthcare and lifesciences organizations meet their patients, members and customers where they are to deliver the right care, at the right time, from anywhere.
BERLIN – October 7, 2024 – EVERSANA , a leading provider of global commercial services to the lifesciences industry, today announced the continued growth of its European footprint with a new office in Berlin, Germany, Europe’s largest pharmaceutical market.
The newly appointed board members are: Jennifer Chavez, Senior Director, BioMed Realty Provides comprehensive commercial real estate transaction expertise and specialized business management services for BioMed Realtys Colorado portfolio, including the 23-building Flatiron Park, a hub for lifescience, quantum and technology innovation.
With the proven success to save on average 48% production time from traditional agency models, TEDAVI meets the dynamic needs of the pharmaceutical and lifescience industries. CHICAGO – Aug. TEDAVI showcases next-generation innovation while reinforcing a commitment to “pharmatize AI.”
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Via the PhilRx Patient Access Platform, patients can now access Teva Pharmaceuticals’ Digihaler® family of inhalers SAN FRANCISCO–(BUSINESS WIRE)– Phil Inc., The goal of Phil and Teva Pharmaceuticals’ partnership is to help enable patients to receive and refill their Digihaler medication quickly, easily and affordably.
Kelly Nguyen is a multi-award-winning, seasoned executive with a proven track record in the pharmaceutical and healthcare industry. Dr. Kelly Nguyen is an experienced entrepreneur and executive with a proven track record in the pharmaceutical and healthcare industry. About Diversity Alliance for Science (DA4S).
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and lifesciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.
EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of lifescience marketing. They are, however, fully owned and operated by EVERSANA.
Built on a strong heritage in health innovation, Newel Health works in partnership with pharmaceutical companies, medical device manufacturers and other health and wellness stakeholders. Its team of experts, comprised of professionals in digital, data, behavioral, and scientific fields, have extensive experience in the lifesciences industry.
Chris McSpiritt, Head of LifeSciences at Domino Data Lab Next year will see AI-enhanced imaging technologies significantly improve diagnostic accuracy in radiology and pathology, empowering clinicians to make quicker and more reliable decisions at the point of care.
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and LifeSciences Institute. delivery and financing system.
The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups.
The acquisition expands Linus Health’s operations into the lifesciences industry. Aural Analytics’ speech analytics software, called Speech Vitals, is used by leading healthcare systems and lifescience organizations in pharmaceutical research and clinical trials.
Having worked within a variety of pharmaceutical organizations, Henry added that Cappellino is also a seasoned pro when it comes to approaching market access with a client-side perspective in mind. “We About Klick Health Klick Health is the world’s largest independent commercialization partner for lifesciences.
Pharmaceuticals garner the lowest score at 57, compared with biotech and lifesciences at 64. It’s important to note differences in trust across the five healthcare industry segments — and there are big differences.
However, while DTP technology could empower patients to advocate for the best possible treatment options, members of Congress and others are concerned about the potential conflict of interest for pharmaceutical companies offering direct sales. Lawmakers recently asked pharmaceutical companies questions about their tapping into virtual care.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content